Zai Lab Q1 2022 results; excerpts lack financials; auditor, share split, COO announced

Zai Lab Ltd

2023-Q1 EPS reported -$0.09 revenue$46,724,000

Announced Q1 2022 financial results on May 10, 2022; specific revenue and earnings figures not visible in the provided excerpt.
Engaged KPMG as independent auditor for FY2022, replacing prior auditor, to comply with PCAOB inspection and Nasdaq listing requirements.
Shareholders approved 1-for-10 ordinary share subdivision effective March 30, 2022, aimed at increasing liquidity and lowering trading price.
Appointed Josh Smiley as COO effective August 2022; he brings over 26 years of biopharmaceutical industry experience.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.